FDA warned Secret of the Islands that its salt scrub products are unapproved and misbranded drugs because of COVID-19 claims.
What happened
FDA reviewed the company’s website on July 26, 2021, and its Facebook page, which directs consumers to the website to buy products. FDA found various salt scrub products offered for sale with claims that they kill or deactivate the Coronavirus and are doctor-approved anti-bacterial and anti-viral. FDA says these claims make the products unapproved new drugs (drugs FDA has not approved) and misbranded drugs (drugs with false or misleading labeling).
What FDA found
The salt scrub products are unapproved new drugs because the company intends them to prevent or treat COVID-19 without FDA approval.
Section 505(a) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 355(a)The products are misbranded drugs under the FD&C Act.
Section 502 of the FD&C Act, 21 U.S.C. § 352Introducing or delivering these products into interstate commerce is prohibited.
Sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d)The website claims the salt scrub is a doctor-approved anti-bacterial and anti-viral product that kills or deactivates the Coronavirus.
The website says there is a shortage of 12 oz jars due to the Coronavirus, tying the product to COVID-19.
What FDA wants
FDA tells the company to immediately stop selling the products and, within 48 hours, email a description of steps taken, how it will prevent recurrence, and related documents.
Who should pay attention
- retailers and online marketplaces selling salt scrubs or cosmetics with COVID-19 claims
- cosmetic and personal-care brands that make antiviral or antibacterial claims
- companies marketing products during public health emergencies
This is a summary. Read the original letter on fda.gov.